Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer
NCT05034133
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Limited Stage Small Cell Lung Cancer
Interventions
DRUG:
Durvalumab
Sponsor
Beijing Haidian Hospital